The Fos family of transcription factors and their role in tumourigenesis

European Journal of Cancer

Volumn 41, Issue 16, 2005, Pages 2449-2461

  Milde Langosch, Karin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

AP 1; c Fos; Cancer; FosB; Fra 1; Fra 2; Invasion; Transformation

Indexed keywords

PROTEIN C FOS; PROTEIN FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2;

BONE TUMOR; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CANCER; ENDOMETRIUM CARCINOMA; ESOPHAGUS CANCER; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HELA CELL; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; MESOTHELIOMA; METASTASIS; NASOPHARYNX CARCINOMA; NONHUMAN; ONCOGENE C FOS; OSTEOSARCOMA; OVARY CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CANCER; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKIN TUMOR; THYROID CARCINOMA; TUMOR CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

EID: 27544468372     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.08.008     Document Type: Article

References (104)

1. W.W. Lamph, P. Wamsley, and P. Sassone-Corsi Induction of proto-oncogene JUN/AP-1 by serum and TPA Nature 334 1988 629 631
2. D.A. Miller, T. Curran, and I.M. Verma c-fos protein can induce cellular transformation: a novel mechanism of a cellular oncogene Cell 36 1984 51 60
3. T.D. Halazonetis, K. Georgopoulos, and M.E. Greenberg c-jun dimerises with itself and with c-fos, forming complexes of different DNA binding affinities Cell 55 1988 917 924
4. R.-P. Ryseck, and R. Bravo c-Jun, JunB, and JunD differ in their binding affinities to AP-1 and CRE consensus sequences: effect of fos proteins Oncogene 6 1991 533 542
5. J. Schütte, J. Viallet, and M. Nau Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun Cell 59 1989 987 997
6. R. Wisdom, and I.M. Verma Transformation by fos proteins requires a C-terminal transactivation domain Mol Cell Biol 13 1993 7429 7438
7. E. Tulchinsky Fos family members: regulation, structure and role in oncogenic transformation Histol Histopathol 15 2000 921 928
8. M.C. Gruda, K. Kovary, and R. Metz Regulation of fra-1 and fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity Oncogene 9 1994 2537 2547
9. T.W. Hurd, A.A. Culbert, and K.J. Webster Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra1 (fos-related antigen-1) transcription and phosphorylation Biochem J 368 2002 573 580
10. S.F. Rosenberger, J.S. Finch, and A. Gupta Extracellular signal-regulated kinase 1/2-mediated phosphorylation of JUnD and FosB is required for ocadaic acid-induced activator protein 1 activation J Biol Chem 274 1999 1124 1130
11. H. van Dam, and M. Castellazzi Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis Oncogene 20 2001 2453 2464
12. E. Shaulian, and M. Karin AP-1 as a regulator of cell life and death Nat Cell Biol 4 2002 E131 E136
13. W. Jochum, E. Passegué, and E.F. Wagner AP-1 in mouse development and tumourigenesis Oncogene 20 2001 2401 2412
14. E. Shaulian, and M. Karin AP-1 in cell proliferation and survival Oncogene 20 2001 2390 2400
15. A.E. Grigoriadis, K. Schellander, and Z.Q. Wang Osteoblasts are target cells for transformation in c-fos transgenic mice J Cell Biol 122 1993 685 701
16. A. Sunters, J. McCluskey, and A.E. Grigoriadis Control of cell cycle gene expression in bone development and during c-fos-induced osteosarcoma formation Dev Genet 22 1998 386 397
17. A. Sunters, D.P. Thomas, and W.A. Yeudall Accelerated cell cycle progression in osteoblasts overexpressing the c-fos proto-oncogene: induction of cyclin A and enhanced cdk2 activity J Biol Chem 279 2004 9882 9891
18. A. Franchi, A. Calzolari, and G. Zampi Immunohistochemical detection of c-fos and c-jun expression in oseous and cartilaginous tumours of the skeleton Virchows Arch 432 1998 515 519
19. D.J. Papachristou, A. Batistatou, and G.P. Sykiotis Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas Bone 32 2003 364 371
20. G. Gamberi, M.S. Benassi, and T. Bohling C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression Oncology 55 1998 556 563
21. S. Kakar, M. Mihalov, and N.A. Chachlani Correlation of c-fos, p53, and PCNA expression with treatment outcome in osteosarcoma J Surg Oncol 73 2000 125 126
22. Z.Q. Wang, A.E. Grigoriadis, and U. Mohle-Steinlein A novel target cell for c-fos-induced carcinogenesis: development of chondrogenic tumours in embryonic stem cell chimeras EMBO J 10 1991 2437 2450
23. J.S. Weisstein, R.J. Majeska, and M.J. Klein Detection of c-fos expression in benign and malignant musculoskeletal lesions J Orthop Res 19 2001 339 345
24. O. Kustikova, D. Kramerov, and M. Grigorian Fra-1 induces morphological transformation and increases in vitro invasiveness and mobility of epithelioid adenocarcinoma cells Mol Cell Biol 18 1998 7095 7105
25. H. Andersen, S. Mahmood, and V. Tkach The ability of Fos family members to produce phenotypic changes in epitheloid cells is not directly linked to their transactivation potentials Oncogene 21 2002 4843 4848
26. V. Tkach, E. Tulchinsky, and E. Lukanidin Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility Oncogene 22 2003 5045 5054
27. D.A. Zajchowski, M.F. Bartholdi, and Y. Gong Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells Cancer Res 61 2001 5168 5178
28. A.-M. Bamberger, C. Methner, and B.W. Lisboa Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive phenotype Int J Cancer 84 1999 553 558
29. A. Philips, C. Teyssier, and F. Galtier Fra-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells Mol Endocrinol 12 1998 973 985
30. K. Milde-Langosch, H. Röder, and B. Andritzky The role of the transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas Breast Cancer Res Tr 86 2004 139 152
31. K. Belguise, N. Kersual, and F. Galtier Fra-1 expression level regulates proliferation and invasiveness of breast cancer cells Oncogene 24 2005 1434 1444
32. E. Vial, E. Sahai, and C.J. Marshall ERK-MAPK signalling coordinately regulates activity of Rac1 and RhoA for tumour cell motility Cancer cell 4 2003 67 79
33. A.M. Bamberger, K. Milde-Langosch, and H.M. Schulte Progesterone receptor isoforms PR-B and PR-A in breast cancer: correlations with clinico-pathologic tumour parameters and expression of AP-1 factors Hormone Res 54 2000 32 37
34. K. Milde-Langosch, H. Kappes, and S. Riethdorf FosB is highly expressed in normal mammary epithelia, but down-regulated in poorly differentiated breast carcinomas Breast Cancer Res Tr 77 2003 265 275
35. K. Milde-Langosch, A.M. Bamberger, and C. Methner Expression of cell cycle regulatory proteins Rb, p16/MTS1, p27/Kip1, p21/Waf1, cyclin D1 and cyclin E in breast cancer: correlations with expression of activating protein-1 family members Int J Cancer 87 2000 468 472
36. I. Bièche, F. Lerebours, and S. Tozlu Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature Clin Cancer Res 10 2004 6789 6795
37. J. Fujimoto, M. Hori, and S. Ichigo Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers Eur J Gynaecol Oncol 16 1995 138 146
38. Y. Yokoyama, M. Sagara, and S. Sato Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas Gynecol Oncol 68 1998 280 287
39. K.P. Nephew, C.M. Choi, and T.C. Polek Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue Gynecol Oncol 76 2000 388 396
40. A. Salmi, O. Carpen, and E. Rutanen The association between c-fos and c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer Tumour Biol 20 1999 202 211
41. A.-M. Bamberger, K. Milde-Langosch, and E. Rössing Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators J Cancer Res Clin Oncol 127 2001 545 550
42. H. zur Hausen Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types Curr Top Microbiol Immunol 186 1994 131 156
43. G.M. Clifford, J.S. Smith, and M. Plummer Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis Br J Cancer 88 2002 63 73
44. K. Milde-Langosch, S. Riethdorf, and T. Löning Association of HPV-infection and carcinomas of the cervix uteri: theoretical and practical implications Virchows Arch 437 2000 227 233
45. F. Rösl, B.C. Das, and M. Lengert Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription J Virol 71 1997 362 370
46. U. Soto, B.C. Das, and M. Lengert Conversion of HPV18 positive non-tumourigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex Oncogene 18 1999 3187 3198
47. U. Soto, C. Denk, and P. Finzer Genetic complementation to non-tumourigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition Int J Cancer 86 2000 811 817
48. C. Talora, D.C. Sgroi, and C.P. Crum Specific down-modulation of Notch1 signalling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation Genes Develop 16 2002 2252 2263
49. B.K. Prusty, and B.C. Das Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papilomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin Int J Cancer 113 2005 951 960
50. M.R. Bani, M.I. Nicoletti, and N.W. Alkharouf Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts Mol Cancer Ther 3 2004 111 121
51. R.A. Moorehead, and G. Singh Influence of the proto-oncogene c-fos on cisplatin sensitivity Biochem Pharmacol 59 2000 337 345
52. M. Bonovich, M. Olive, and E. Reed Adenoviral delivery of A-Fos, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines Cancer Gene Ther 9 2002 62 70
53. H. Tsuda, M.J. Birrer, and Y.M. Ito Identification of DNA copy number changes in microdissected erous ovarian cancer tissue using a cDNA microarray platform Cancer Genet Cytogenet 155 2004 97 107
54. O.I. Tchernitsa, C. Sers, and J. Zuber Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells Oncogene 23 2004 4536 4555
55. S. Hapke, H. Kessler, and B. Luber Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha (v)beta3/vitronectin interaction Biol Chem 384 2003 1073 1083
56. M.E. Ramos-Nino, C.R. Timblin, and B.T. Mossman Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression Cancer Res 62 2002 6065 6069
57. M.E. Ramos-Nino, L. Scapoli, and M. Martinelli Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma Cancer Res 63 2003 3539 3545
58. A.P.M. Reddy, and B.T. Mossmann Role and regulation of activator protein-1 in toxicant-induced responses of the lung Am J Physiol Lung Cell Mol Physiol 283 2002 L1161 L1178
59. Q. Zhang, P. Adiseshaiah, and S.P. Reddy Matrix metalloproteinase/ epidermal growth factor receptor/mitogen-activated protein kinase signalling regulate fra-1 induction by cigarette smoke in lung epithelial cells Am J Respir Cell Mol Biol 32 2005 72 81
60. W.J. Levin, M.F. Press, and R.B. Gaynor Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group Oncogene 11 1995 1261 1269
61. M. Volm, and J. Mattern Correlation between successful heterotransplantation of lung tumours in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras Anticancer Res 13 1993 2021 2025
62. M. Volm, W. Rittgen, and P. Drings Prognostic value of ErbB-1, VEGF, cyclin A, Fos, Jun and Myc in patients with squamous cell lung carcinomas Br J Cancer 77 1998 663 669
63. M. Volm, R. Koomägi, and J. Mattern Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients Clin Cancer Res 8 2002 1843 1848
64. W. Wodrich, and M. Volm Overexpression of oncoproteins in non-small cell lung carcinomas of smokers Carcinogenesis 14 1993 1121 1124
65. G. Risse-Hackl, J. Adamkiewicz, and A. Wimmel Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins Oncogene 16 1998 3057 3068
66. E. Vial, and C.J. Marshall Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells J Cell Sci 116 2003 4957 4963
67. B. Mann, M. Gelos, and A. Siedow Taret genes of β-catenin-Tcell- factor/lymphoid-enhancer-factosignalling signalling in human colorectal carcinomas Proc Natl Acad Sci USA 96 1999 1603 1608
68. H.L. Wang, J. Wang, and S.Y. Xiao Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-myc in human colorectal adenocarcinomas overexpressing beta-catenin Int J Cancer 101 2002 301 310
69. P. Angel, A. Szabowski, and M. Schorpp-Kistner Function and regulation of AP-1 subunits in skin physiology and pathology Oncogene 20 2001 2413 2423
70. D.C. Ng, S. Shafaee, and D. Lee Requirement of an AP-1 site in the calcium response region of the involucrin promoter J Biol Chem 275 2000 24080 24088
71. E. Saez, S.E. Rutberg, and E. Mueller c-Fos is required for malignant progression of skin tumours Cell 82 1995 721 732
72. A.L. Silvers, M.A. Bachelor, and G.T. Bowden The role of JNK and p38 MAPK activities in UVA-induced signalling pathways leading to AP-1 activation and c-fos expression Neoplasia 5 2003 319 329
73. N. Sakai Chemical carcinogenesis is accelerated in c-fos transgenic mice Kobe J Med Sci 36 1990 37 53
74. V. Zoumpourlis, P. Papassava, and S. Linardopoulos High levels of phosphorylated c-jun, fra-1, fra-2, and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model Oncogene 19 2000 4011 4021
75. M.M. Serewko, C. Popa, and A.L. Dahler Alterations in gene expression and activity during squamous cell carcinoma development Cancer Res 62 2002 3759 3765
76. S. Yang, S. McNulty, and F.L.J. Meyskens During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro Pigment Cell Res 17 2004 74 83
77. S. Yang, and F.L.J. Meyskens Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratol in human melanoma Mol Pharmacol 67 2005 298 308
78. D. Vallone, S. Battista, and G.M. Pierantoni Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product EMBO J 16 1997 5310 5321
79. G. Liu, T. Takano, and H. Matsuzuka Screening of specific changes in mRNAs in thyroid tumours by sequence specific differential display: decreased expression of c-Fos mRNA in papillary carcinoma Endocr J 46 1999 459 466
80. G. Chiapetta, G. Tallini, and M.C. De Biasio Fra-1 expression in hyperplastic and neoplastic thyroid diseases Clin Cancer Res 6 2000 4300 4307
81. Y.H. Kim, J.H. Oh, and N.H. Kim Fra-1 expression in malignant and benign thyroid tumour Korean J Intern Med 16 2001 93 97
82. M.-Y. Wu, C.-X. Zhuang, and H.-X. Yang Expression of Egr-1, c-Fos, and cyclin D1 in esophageal cancer and its precursors: an immunohistochemical and in situ hybridisation study World J Gastroenterol 10 2004 476 480
83. Y.C. Hu, K.Y. Lam, and S. Law Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA 3expression array: overeyxpression of fra-1, neogenin, Id-1, and CDC25B genes in ESCC Clin Cancer Res 7 2001 2213 2221
84. M. Mikula, J. Gotzmann, and A. Fischer The proto-oncogene c-Fos negatively regulates hepatocellular tumourigenesis Oncogene 22 2003 6725 6738
85. T. Ohta, E. Sueoka, and N. Iida Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver Cancer Res 54 1994 6402 6406
86. M.F. Yuen, P.C. Wu, and V.C. Lai Expression of c-Myc, c-Fos and c-Jun in hepatocellular carcinoma Cancer 91 2001 106 112
87. J. Borlak, T. Meier, and R. Halter Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours Oncogene 24 2005 1809 1819
88. T. Meyer-ter-Vehn, A. Covacci, and M. Kist Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun J Biol Chem 275 2000 16064 16072
89. G. Troen, V. Nygaard, and T.-K. Jenssen Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marbinal zone lymphoma J Mol Diagn 6 2004 297 307
90. H. Tsuchiya, M. Fujii, and T. Niki Human T-cell leukemia virus type 1 Tax activates transcription of the human fra-1 gene through multiple cis elements responsive to transmembrane signals J Virol 67 1993 7001 7007
91. J. Edwards, N.S. Krishna, and R. Mukherjee The role of c-Jun and c-Fos expression in androgen-independent prostate cancer J Pathol 204 2004 153 158
92. L.F. Zerbini, Y. Wang, and J.Y. Cho Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer Cancer Res 63 2003 2206 2215
93. N. Tarbé, S. Losch, and H. Burtscher Identification of rat pancreatic carcinoma genes with lymphogenous metastasis Anticancer Res 22 2002 2015 2027
94. J. Agaki, H. Egami, and T. Kurizaki Signal transduction pathway of the induction of cell motility in hamster pancreatic ductal adenocarcinoma cell Invas Metast 17 1997 16 25
95. C.S. Lee, and D. Charalambous Immunohistochemical localization of teh c-fos oncoprotein in pancreatic cancers Zentralbl Pathol 140 1994 271 275
96. K. Wakita, H. Ohyanagi, and K. Yamamoto Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas Int J Pancreatol 11 1992 43 47
97. M.M. Pacheco, L.P. Kowalski, and I.N. Nishimoto Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: associations with uPA, gelatinase B, and matrilysin mRNAs Head Neck 24 2002 24 32
98. S.O. De Sousa, R.A. Mesquita, and D.S. Pinto Jr. Immunolocalization of c-Fos and c-Jun in human oral mucosa and in oral squamous cell carcinoma J Oral Pathol Med 31 2002 78 81
99. F.G. Ondrey, G. Dong, and J. Sunwoo Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines Mol Carcinogen 26 1999 119 129
100. A. Maruya, H.-W. Kim, and R.S. Weber Gene expression screening of salivary gland neoplasms J Mol Diagn 6 2004 180 190
101. L.F. Fung, A.K.F. Lo, and P.W. Yuen Differential gene expression in nasopharyngeal carcinoma cells Life Sci 67 2000 923 936
102. A. Fleischmann, F. Hafezi, and C. Elliott Fra-1 replaces c-Fos-dependent functions in mice Genes Develop 14 2000 2695 2700
103. J.Y. Chung, C. Huang, and X. Meng Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras transformed cells: structure-activity relationship and mechanisms involved Cancer Res 59 1999 4610 4617
104. Y. Luo, H. Zhou, and M. Mizutani Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine Proc Natl Acad Sci USA 100 2003 8850 8855